Clinical trial
SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate
NCT00089921 · Scios, Inc., Industry · Completed
Key facts
| NCT number | NCT00089921 |
|---|---|
| Title | SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate |
| Official title | A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469 in Subjects With Active Rheumatoid Arthritis Who Are Not Receiving DMARDs Other Than Hydroxychloroquine |
| Lead sponsor | Scios, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | SCIO-469, Placebo |
| Enrollment | 302 |
| Start date | Jul 1, 2004 |
| Completion | Oct 1, 2005 |
| First posted | Aug 20, 2004 |
| Last update posted | Oct 18, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: